• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从担子菌纲灵芝属的南方灵芝 GPC191 中生物勘探新型 L-天冬酰胺酶产生菌。

Bioprospecting of the agaricomycete Ganoderma australe GPC191 as novel source for L-asparaginase production.

机构信息

Department of Microbiology, School of Sciences, Block-1, JAIN (Deemed To-Be University), 18/3, 9th Main Road, 3rd Block, Jayanagar, Bengaluru, 560011, Karnataka, India.

出版信息

Sci Rep. 2021 Mar 18;11(1):6192. doi: 10.1038/s41598-021-84949-5.

DOI:10.1038/s41598-021-84949-5
PMID:33737513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7973716/
Abstract

L-Asparaginase is a therapeutically and industrially-competent enzyme, acting predominantly as an anti-neoplastic and anti-cancerous agent. The existing formulations of prokaryotic L-asparaginase are often toxic and contain L-glutaminase and urease residues, thereby increasing the purification steps. Production of L-glutaminase and urease free L-asparaginase is thus desired. In this research, bioprospecting of isolates from the less explored class Agaricomycetes was undertaken for L-asparaginase production. Plate assay (using phenol red and bromothymol blue dyes) was performed followed by estimation of L-asparaginase, L-glutaminase and urease activities by Nesslerization reaction for all the isolates. The isolate displaying the desired enzyme production was subjected to morphological, molecular identification, and phylogenetic analysis with statistical validation using Jukes-Cantor by Neighbour-joining tree of Maximum Likelihood statistical method. Among the isolates, Ganoderma australe GPC191 with significantly high zone index value (5.581 ± 0.045 at 120 h) and enzyme activity (1.57 ± 0.006 U/mL), devoid of L-glutaminase and urease activity was selected. The present study for the first-time reported G. australe as the potential source of L-glutaminase and urease-free L-asparaginase and also is one of the few studies contributing to the literature of G. australe in India. Hence, it can be postulated that it may find its future application in pharmaceutical and food industries.

摘要

L-天冬酰胺酶是一种具有治疗和工业应用价值的酶,主要作为一种抗肿瘤和抗癌药物。现有的原核 L-天冬酰胺酶制剂通常具有毒性,并含有 L-谷氨酰胺酶和脲酶残留,从而增加了纯化步骤。因此,需要生产无 L-谷氨酰胺酶和脲酶的 L-天冬酰胺酶。在这项研究中,对来自探索较少的担子菌纲 Agaricomycetes 类的分离物进行了生物勘探,以生产 L-天冬酰胺酶。进行了平板检测(使用苯酚红和溴百里酚蓝染料),然后通过 Nessler 化反应对所有分离物的 L-天冬酰胺酶、L-谷氨酰胺酶和脲酶活性进行了估计。显示所需酶生产的分离物进行了形态学、分子鉴定和系统发育分析,并使用基于最大似然统计方法的邻接法的 Jukes-Cantor 进行了统计验证。在分离物中,选择了具有显著高带指数值(120 小时时为 5.581±0.045)和酶活性(1.57±0.006 U/mL)的赤芝 GPC191,且不含 L-谷氨酰胺酶和脲酶活性。本研究首次报道了赤芝是无 L-谷氨酰胺酶和脲酶的 L-天冬酰胺酶的潜在来源,也是为数不多的对印度赤芝文献有贡献的研究之一。因此,可以推断它可能在制药和食品工业中找到未来的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddeb/7973716/11414ebbe469/41598_2021_84949_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddeb/7973716/7e8b7e1fe979/41598_2021_84949_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddeb/7973716/6de31820ffe3/41598_2021_84949_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddeb/7973716/3401b4bd2b91/41598_2021_84949_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddeb/7973716/11414ebbe469/41598_2021_84949_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddeb/7973716/7e8b7e1fe979/41598_2021_84949_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddeb/7973716/6de31820ffe3/41598_2021_84949_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddeb/7973716/3401b4bd2b91/41598_2021_84949_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddeb/7973716/11414ebbe469/41598_2021_84949_Fig4_HTML.jpg

相似文献

1
Bioprospecting of the agaricomycete Ganoderma australe GPC191 as novel source for L-asparaginase production.从担子菌纲灵芝属的南方灵芝 GPC191 中生物勘探新型 L-天冬酰胺酶产生菌。
Sci Rep. 2021 Mar 18;11(1):6192. doi: 10.1038/s41598-021-84949-5.
2
Purification and anticancer activity of glutaminase and urease free intracellular l-asparaginase from Chaetomium sp.来自毛壳菌属的无谷氨酰胺酶和脲酶的细胞内L-天冬酰胺酶的纯化及抗癌活性
Protein Expr Purif. 2022 Feb;190:106006. doi: 10.1016/j.pep.2021.106006. Epub 2021 Nov 4.
3
Microbes Producing L-Asparaginase free of Glutaminase and Urease isolated from Extreme Locations of Antarctic Soil and Moss.从南极土壤和苔藓的极端环境中分离出的产 L-天冬酰胺酶且不产谷氨酰胺酶和脲酶的微生物。
Sci Rep. 2019 Feb 5;9(1):1423. doi: 10.1038/s41598-018-38094-1.
4
Application of sequential design for enhanced L-asparaginase synthesis from Ganoderma australe GPC191.应用序贯设计提高灵芝 GPC191 产 L-天冬酰胺酶的研究。
World J Microbiol Biotechnol. 2024 Feb 1;40(3):85. doi: 10.1007/s11274-023-03881-0.
5
Isolation and screening of L-asparaginase free of glutaminase and urease from fungal sp.从真菌菌株中分离和筛选不含谷氨酰胺酶和脲酶的L-天冬酰胺酶
3 Biotech. 2016 Dec;6(2):239. doi: 10.1007/s13205-016-0544-1. Epub 2016 Nov 12.
6
Purification and anticancer activity of glutaminase and urease-free l-asparaginase from novel endophyte Chaetomium sp.新型内生真菌拟青霉来源的谷氨酰胺酶和脲酶缺失天冬酰胺酶的纯化及其抗癌活性
Biotechnol Appl Biochem. 2022 Oct;69(5):2161-2175. doi: 10.1002/bab.2276. Epub 2021 Nov 12.
7
Production, purification and kinetic characterization of glutaminase free anti-leukemic L-asparaginase with low endotoxin level from novel soil isolate.新型土壤分离株来源的无谷氨酰胺酶、低内毒素的抗白血病 L-天冬酰胺酶的生产、纯化和动力学特征。
Prep Biochem Biotechnol. 2020;50(3):260-271. doi: 10.1080/10826068.2019.1692221. Epub 2019 Nov 23.
8
Development of medium for enhanced production of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428.用于从胡萝卜软腐果胶杆菌MTCC 1428中提高无谷氨酰胺酶L-天冬酰胺酶产量的培养基的开发。
Appl Microbiol Biotechnol. 2009 Sep;84(3):477-86. doi: 10.1007/s00253-009-1973-0. Epub 2009 Apr 8.
9
Production and structural modeling of a novel asparaginase in Yarrowia lipolytica.在解脂耶氏酵母中生产和结构建模新型天冬酰胺酶。
Int J Biol Macromol. 2019 Mar 15;125:955-961. doi: 10.1016/j.ijbiomac.2018.12.162. Epub 2018 Dec 18.
10
Purification and characterization of a novel and robust L-asparaginase having low-glutaminase activity from Bacillus licheniformis: in vitro evaluation of anti-cancerous properties.从地衣芽孢杆菌中纯化和鉴定一种新型且具有低谷氨酰胺酶活性的强效L-天冬酰胺酶:抗癌特性的体外评估
PLoS One. 2014 Jun 6;9(6):e99037. doi: 10.1371/journal.pone.0099037. eCollection 2014.

引用本文的文献

1
Enzyme-Based Anti-Inflammatory Therapeutics for Inflammatory Diseases.用于炎症性疾病的基于酶的抗炎疗法
Pharmaceutics. 2025 May 2;17(5):606. doi: 10.3390/pharmaceutics17050606.
2
Desirable L-asparaginases for treating cancer and current research trends.用于治疗癌症的理想L-天冬酰胺酶及当前研究趋势。
Front Microbiol. 2024 Mar 13;15:1269282. doi: 10.3389/fmicb.2024.1269282. eCollection 2024.
3
Endophytic Fungi as a Promising Source of Anticancer L-Asparaginase: A Review.内共生真菌作为抗癌 L-天冬酰胺酶的有前途的来源:综述。

本文引用的文献

1
Optimization of aqueous two-phase micellar system for partial purification of L-asparaginase from Penicillium sp. grown in wheat bran as agro-industrial residue.优化水相两亲胶束体系,从麦麸农业工业废渣中生长的青霉属中部分纯化 L-天冬酰胺酶。
Braz J Microbiol. 2020 Sep;51(3):979-988. doi: 10.1007/s42770-020-00269-2. Epub 2020 May 18.
2
Toxicity Profile of PEG-Asparaginase in Adult Patients With Acute Lymphoblastic Leukemia in Brazil: A Multicenter Cross-Sectional Study.巴西成人急性淋巴细胞白血病患者聚乙二醇天冬酰胺酶的毒性概况:一项多中心横断面研究。
Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):e523-e528. doi: 10.1016/j.clml.2020.04.001. Epub 2020 Apr 13.
3
Curr Microbiol. 2023 Jul 14;80(9):282. doi: 10.1007/s00284-023-03392-z.
4
Thermostability enhancement and insight of L-asparaginase from Mycobacterium sp. via consensus-guided engineering.通过共识指导工程提高分枝杆菌来源天冬酰胺酶的热稳定性
Appl Microbiol Biotechnol. 2023 Apr;107(7-8):2321-2333. doi: 10.1007/s00253-023-12443-1. Epub 2023 Feb 27.
5
Overview of the structure, side effects, and activity assays of l-asparaginase as a therapy drug of acute lymphoblastic leukemia.L-天冬酰胺酶作为急性淋巴细胞白血病治疗药物的结构、副作用及活性测定概述
RSC Med Chem. 2022 Jan 12;13(2):117-128. doi: 10.1039/d1md00344e. eCollection 2022 Feb 23.
6
Characterization of a Novel L-Asparaginase from with Acrylamide Mitigation Potential.一种具有缓解丙烯酰胺潜力的新型L-天冬酰胺酶的特性分析。
Foods. 2021 Nov 16;10(11):2819. doi: 10.3390/foods10112819.
PEGylated versus non-PEGylated drugs: A cross-sectional analysis of adverse events in the FDA Adverse Event Reporting System (FAERS) Database
.
聚乙二醇化药物与非聚乙二醇化药物:美国食品药品监督管理局不良事件报告系统(FAERS)数据库中不良事件的横断面分析
Int J Clin Pharmacol Ther. 2020 Jun;58(6):332-342. doi: 10.5414/CP203735.
4
Characterization of a novel type I l-asparaginase from Acinetobacter soli and its ability to inhibit acrylamide formation in potato chips.从土壤固氮不动杆菌中鉴定新型 I 型 L-天冬酰胺酶及其抑制薯片丙烯酰胺形成的能力。
J Biosci Bioeng. 2020 Jun;129(6):672-678. doi: 10.1016/j.jbiosc.2020.01.007. Epub 2020 Feb 20.
5
Rewiring of Metabolic Network in During Adaptation to Different Stresses.适应不同胁迫过程中代谢网络的重布线。
Front Microbiol. 2019 Oct 29;10:2417. doi: 10.3389/fmicb.2019.02417. eCollection 2019.
6
A new record of (Basidiomycota, Polyporales) for Thailand and first assessment of optimum conditions for mycelia production.泰国(担子菌门,多孔菌目)的一个新记录及菌丝体生产最佳条件的首次评估。
MycoKeys. 2019 May 7;51:65-83. doi: 10.3897/mycokeys.51.33513. eCollection 2019.
7
Microbes Producing L-Asparaginase free of Glutaminase and Urease isolated from Extreme Locations of Antarctic Soil and Moss.从南极土壤和苔藓的极端环境中分离出的产 L-天冬酰胺酶且不产谷氨酰胺酶和脲酶的微生物。
Sci Rep. 2019 Feb 5;9(1):1423. doi: 10.1038/s41598-018-38094-1.
8
: A Cancer Immunotherapy Review.一篇癌症免疫疗法综述。
Front Pharmacol. 2018 Oct 25;9:1217. doi: 10.3389/fphar.2018.01217. eCollection 2018.
9
Identification and validation of l-asparaginase as a potential metabolic target against Mycobacterium tuberculosis.鉴定和验证 l-天冬酰胺酶作为抗结核分枝杆菌的潜在代谢靶标。
J Cell Biochem. 2019 Jan;120(1):143-154. doi: 10.1002/jcb.27169. Epub 2018 Sep 19.
10
Isolation and screening of L-asparaginase free of glutaminase and urease from fungal sp.从真菌菌株中分离和筛选不含谷氨酰胺酶和脲酶的L-天冬酰胺酶
3 Biotech. 2016 Dec;6(2):239. doi: 10.1007/s13205-016-0544-1. Epub 2016 Nov 12.